,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.0,Disorientation,16811625
1,6,22.0,Haemoptysis,16811625
2,6,22.0,Stress,16811625
3,6,22.0,Confusional state,16811625
4,6,22.0,Anxiety,16811625
5,6,22.0,Overdose,16811625
6,1,22.0,Vomiting,16811625
7,6,22.0,Peripheral swelling,16811625
8,1,22.0,Nausea,16811625
0,6,22.0,Fatigue,16811628
0,3,22.1,Drug ineffective,16811644
1,3,22.1,Product adhesion issue,16811644
0,5,22.0,Malignant neoplasm progression,16811664
0,1,22.1,Oedema peripheral,16811719
1,6,22.1,Weight increased,16811719
2,1,22.1,Depression,16811719
0,2,22.0,Osteonecrosis,16811759
0,6,22.0,Anaemia,16811760
0,3,22.0,Ejection fraction decreased,16811803
0,1,22.0,Administration site extravasation,16811809
0,1,22.0,Renal failure,16811823
0,2,22.0,Acute coronary syndrome,16811830
0,1,22.0,Malaise,16811878
0,6,22.0,Diarrhoea,16811892
1,6,22.0,Vomiting,16811892
2,6,22.0,Quadriplegia,16811892
3,6,22.0,Hypokalaemia,16811892
0,5,22.0,Respiratory failure,16811922
1,6,22.0,Interstitial lung disease,16811922
0,6,22.0,Nephropathy toxic,16811938
0,6,22.0,Coma,16811961
1,6,22.0,Hemiplegia,16811961
2,5,22.0,Brain herniation,16811961
3,6,22.0,Vertebral artery thrombosis,16811961
4,6,22.0,Cerebrovascular accident,16811961
5,6,22.0,Carotid artery thrombosis,16811961
0,1,22.1,General physical health deterioration,16811963
0,6,22.0,Rash maculo-papular,16811964
0,6,22.1,Electrocardiogram PR shortened,16811978
1,6,22.1,Electrocardiogram T wave abnormal,16811978
2,2,22.1,Nausea,16811978
3,1,22.1,Vomiting,16811978
4,6,22.1,Left atrial enlargement,16811978
5,6,22.1,Ventricular extrasystoles,16811978
0,6,22.0,Liver disorder,16811996
1,6,22.0,Product use in unapproved indication,16811996
0,1,22.0,Retinopathy,16812024
1,1,22.0,Blindness,16812024
0,6,22.0,Off label use,16812028
1,5,22.0,Pneumonia,16812028
0,6,22.0,Diarrhoea,16812199
1,6,22.0,Xerophthalmia,16812199
2,6,22.0,Abdominal pain,16812199
0,5,22.0,Nephropathy toxic,16812213
0,1,22.1,Chest pain,16812218
1,1,22.1,Respiratory distress,16812218
2,1,22.1,Pyrexia,16812218
3,1,22.1,Pneumonia cytomegaloviral,16812218
4,1,22.1,Dyspnoea,16812218
0,1,22.0,Haemorrhagic diathesis,16812330
0,1,22.0,Infusion related reaction,16812352
0,6,22.0,Metastases to lymph nodes,16812395
1,6,22.0,Therapeutic response decreased,16812395
0,6,22.0,Off label use,16812409
1,6,22.0,Intentional product use issue,16812409
2,5,22.0,Nervous system disorder,16812409
3,1,22.0,Headache,16812409
4,1,22.0,Vomiting,16812409
0,3,22.0,Memory impairment,16812415
1,3,22.0,Hot flush,16812415
0,6,22.0,Neuropathy peripheral,16812598
1,6,22.0,Pruritus generalised,16812598
2,6,22.0,Headache,16812598
0,6,22.1,Product use in unapproved indication,16812622
1,6,22.1,Endometrial cancer recurrent,16812622
0,6,22.1,Chest discomfort,16812715
1,6,22.1,Metastases to bone,16812715
2,6,22.1,Dyspnoea,16812715
3,3,22.1,Pain,16812715
4,2,22.1,Pulmonary congestion,16812715
5,3,22.1,Malignant neoplasm progression,16812715
6,6,22.1,Metastases to lung,16812715
7,3,22.1,Breast cancer,16812715
0,3,22.0,Nausea,16812885
1,3,22.0,Blood count abnormal,16812885
0,3,22.0,Fatigue,16812983
1,3,22.0,Nausea,16812983
0,1,22.0,White blood cell count decreased,16813002
1,1,22.0,Platelet count decreased,16813002
0,6,22.0,Constipation,16813032
0,3,22.0,Headache,16813134
0,1,22.1,Lung disorder,16813210
0,6,22.0,Rash,16813235
1,6,22.0,Alopecia,16813235
2,6,22.0,Abdominal pain,16813235
3,6,22.0,Dyspnoea,16813235
4,6,22.0,Fatigue,16813235
5,6,22.0,Stomatitis,16813235
6,5,22.0,Death,16813235
7,6,22.0,Superior vena cava occlusion,16813235
8,6,22.0,Vomiting,16813235
9,6,22.0,Activated partial thromboplastin time prolonged,16813235
10,6,22.0,Urinary tract infection,16813235
11,3,22.0,Swelling face,16813235
12,6,22.0,Decreased appetite,16813235
13,6,22.0,Cheilitis,16813235
14,6,22.0,Pyrexia,16813235
15,6,22.0,Blood glucose abnormal,16813235
16,6,22.0,Blood creatinine increased,16813235
17,6,22.0,Lipase increased,16813235
18,6,22.0,Blood calcium decreased,16813235
19,6,22.0,Pruritus,16813235
20,6,22.0,Diarrhoea,16813235
21,6,22.0,Weight decreased,16813235
22,6,22.0,Dyspepsia,16813235
23,6,22.0,Back pain,16813235
24,6,22.0,Nasal dryness,16813235
25,6,22.0,Headache,16813235
26,6,22.0,Dry skin,16813235
27,6,22.0,Alanine aminotransferase increased,16813235
28,6,22.0,Peripheral swelling,16813235
29,6,22.0,Gamma-glutamyltransferase increased,16813235
30,6,22.0,Nausea,16813235
31,6,22.0,Taste disorder,16813235
32,6,22.0,Lymphocyte count decreased,16813235
33,6,22.0,Haemoglobin decreased,16813235
0,3,22.1,Colitis,16813238
1,3,22.1,Interstitial lung disease,16813238
2,1,22.1,Immune thrombocytopenic purpura,16813238
0,5,22.0,Pyrexia,16813254
1,5,22.0,Malignant neoplasm progression,16813254
2,5,22.0,Infection,16813254
3,5,22.0,Non-small cell lung cancer,16813254
0,1,22.0,Leukopenia,16813281
0,2,22.1,Fatigue,16813301
1,2,22.1,Amnesia,16813301
2,2,22.1,Diarrhoea,16813301
3,2,22.1,Paraesthesia,16813301
0,2,22.1,Interstitial lung disease,16813302
1,2,22.1,Herpes zoster,16813302
2,2,22.1,Dermatitis acneiform,16813302
0,6,22.1,Skin exfoliation,16813303
1,2,22.1,Compression fracture,16813303
2,2,22.1,Dry skin,16813303
0,1,22.0,Leukopenia,16813311
0,3,22.0,Malignant neoplasm progression,16813328
0,1,22.1,Hypoaesthesia,16813329
0,1,22.0,Neutropenia,16813410
1,1,22.0,Nausea,16813410
2,1,22.0,Drug hypersensitivity,16813410
3,3,22.0,Liver function test increased,16813410
4,1,22.0,Abdominal pain upper,16813410
5,3,22.0,Pyrexia,16813410
6,1,22.0,Decreased appetite,16813410
7,3,22.0,Dry skin,16813410
0,6,22.0,Metastases to central nervous system,16813416
1,6,22.0,Drug intolerance,16813416
0,1,22.0,Hypophysitis,16813436
1,6,22.0,Pneumonia,16813436
2,6,22.0,Sepsis,16813436
3,6,22.0,Chronic obstructive pulmonary disease,16813436
4,6,22.0,Acute respiratory failure,16813436
0,5,22.0,Death,16813450
0,5,22.0,Disease progression,16813475
0,1,22.1,Infection,16813532
1,1,22.1,Vomiting,16813532
2,2,22.1,Cholangitis sclerosing,16813532
3,1,22.1,Diarrhoea,16813532
4,1,22.1,Pneumothorax,16813532
0,6,22.0,Chills,16813557
1,6,22.0,Pyrexia,16813557
2,6,22.0,Autoimmune haemolytic anaemia,16813557
3,6,22.0,Anaphylactic reaction,16813557
0,6,22.0,Pneumocystis jirovecii pneumonia,16813598
0,1,22.0,Headache,16813635
1,1,22.0,Dyspnoea,16813635
2,1,22.0,Pain in extremity,16813635
3,1,22.0,Flushing,16813635
0,2,22.0,Interstitial lung disease,16813640
0,3,22.0,Interstitial lung disease,16813649
0,6,22.1,Ulcer haemorrhage,16813655
0,6,22.0,Anal atresia,16813668
1,6,22.0,Congenital muscle absence,16813668
2,6,22.0,Respiratory disorder neonatal,16813668
3,6,22.0,Cryptorchism,16813668
4,6,22.0,Maternal drugs affecting foetus,16813668
0,1,22.1,Small intestinal obstruction,16813719
0,6,22.0,Cardiac disorder,16813742
0,6,22.1,Influenza,16813813
1,6,22.1,Myalgia,16813813
2,6,22.1,Pain,16813813
3,6,22.1,Nasopharyngitis,16813813
4,6,22.1,Lymphadenopathy,16813813
0,6,22.0,Purulence,16813823
1,6,22.0,Posture abnormal,16813823
2,6,22.0,Hypersensitivity,16813823
0,3,22.0,Tumour marker increased,16813837
0,2,22.1,Dyspepsia,16813853
1,2,22.1,Gastrointestinal hypomotility,16813853
2,2,22.1,Hot flush,16813853
0,6,22.0,Bone pain,16813856
1,6,22.0,Neutropenia,16813856
2,6,22.0,Hepatomegaly,16813856
0,1,22.1,Lung disorder,16813907
0,1,22.0,Neutropenia,16813909
1,1,22.0,Malignant neoplasm progression,16813909
0,1,22.1,Lung disorder,16813910
0,1,22.1,Lung disorder,16813912
0,1,22.1,Lung disorder,16813918
0,6,22.0,Oestrogen receptor positive breast cancer,16813920
1,6,22.0,Metastasis,16813920
2,6,22.0,Disease progression,16813920
0,1,22.0,Pseudocellulitis,16814012
1,1,22.0,Hypersensitivity vasculitis,16814012
0,5,22.0,Death,16814369
0,2,22.0,Guillain-Barre syndrome,16814413
0,6,22.1,Hypersensitivity,16814435
1,6,22.1,Bone marrow toxicity,16814435
0,6,22.0,Hypoaesthesia oral,16814442
0,1,22.0,Blood creatinine increased,16814505
1,1,22.0,Blood creatinine increased,16814505
2,1,22.0,Urosepsis,16814505
0,2,22.1,Gastrointestinal hypomotility,16814523
1,2,22.1,Dyspepsia,16814523
2,2,22.1,Hot flush,16814523
0,2,22.0,Hyponatraemia,16814582
0,3,22.0,Dyspnoea,16814584
1,3,22.0,Myocardial ischaemia,16814584
0,3,22.0,Radiation injury,16814592
1,3,22.0,Muscle injury,16814592
2,6,22.0,Abscess,16814592
3,6,22.0,Surgical failure,16814592
4,3,22.0,Large intestine perforation,16814592
5,6,22.0,Myocardial infarction,16814592
6,6,22.0,Diabetes mellitus,16814592
7,6,22.0,Impaired healing,16814592
8,6,22.0,Infection,16814592
9,3,22.0,Bladder perforation,16814592
0,6,22.1,Respiratory failure,16814609
1,2,22.1,Pneumonitis,16814609
2,6,22.1,Dyspnoea,16814609
0,2,22.1,Paraesthesia,16814611
1,2,22.1,Diarrhoea,16814611
2,2,22.1,Amnesia,16814611
3,2,22.1,Fatigue,16814611
0,2,22.1,Aphthous ulcer,16814720
1,2,22.1,Vomiting,16814720
2,2,22.1,Nausea,16814720
0,,22.1,Myelodysplastic syndrome,16814757
0,,22.1,Malaise,16814765
0,1,22.1,Pemphigoid,16814775
0,6,22.0,Blood sodium decreased,16814840
1,6,22.0,Vomiting,16814840
2,6,22.0,Dehydration,16814840
3,6,22.0,Blood magnesium decreased,16814840
4,6,22.0,Nausea,16814840
0,1,22.0,Hypotension,16814877
1,1,22.0,Back pain,16814877
2,1,22.0,Hallucination,16814877
0,3,22.0,Blister,16814878
1,6,22.0,Lip discolouration,16814878
2,3,22.0,Swelling,16814878
3,6,22.0,Dizziness,16814878
4,6,22.0,Diarrhoea,16814878
0,2,22.0,Haemolytic anaemia,16814898
1,1,22.0,Tremor,16814898
0,2,22.0,Blood creatinine increased,16814900
1,2,22.0,Leukopenia,16814900
0,1,22.1,Nasopharyngitis,16814911
1,1,22.1,Neutropenia,16814911
0,2,22.0,Fatigue,16814915
1,2,22.0,Vomiting,16814915
2,5,22.0,Death,16814915
0,6,22.1,Headache,16814992
1,6,22.1,Depression,16814992
2,6,22.1,General physical health deterioration,16814992
3,6,22.1,Bone pain,16814992
4,6,22.1,Anxiety,16814992
5,6,22.1,Pain,16814992
0,5,22.0,Death,16815110
0,6,22.0,Cholecystitis infective,16815190
0,,22.0,Prostatic specific antigen increased,16815462
0,3,22.0,Blister,16815464
1,3,22.0,Rash,16815464
0,6,22.0,Pulmonary thrombosis,16815492
0,,22.1,Diarrhoea,16815576
1,,22.1,Chest pain,16815576
0,3,22.0,Abdominal pain,16815610
1,3,22.0,Rash maculo-papular,16815610
2,6,22.0,Metastases to liver,16815610
3,1,22.0,Lichen planus,16815610
4,1,22.0,Silent thyroiditis,16815610
5,1,22.0,Hypothyroidism,16815610
6,3,22.0,Tinnitus,16815610
7,6,22.0,Thyroiditis,16815610
8,6,22.0,Intentional product use issue,16815610
0,5,22.0,Death,16815611
0,6,22.0,Off label use,16815762
1,6,22.0,Drug ineffective for unapproved indication,16815762
2,6,22.0,Prescription drug used without a prescription,16815762
0,1,22.0,Diarrhoea,16815816
1,1,22.0,Acute kidney injury,16815816
0,1,22.0,Urinary tract infection,16815836
1,1,22.0,Bone marrow infiltration,16815836
0,6,22.1,Neutropenia,16815963
1,6,22.1,Leukopenia,16815963
0,6,22.0,Drug ineffective,16815989
1,6,22.0,Hot flush,16815989
2,6,22.0,Product dispensing error,16815989
3,6,22.0,Product substitution issue,16815989
4,6,22.0,Suicidal ideation,16815989
0,1,22.0,Product use in unapproved indication,16816048
1,6,22.0,Application site rash,16816048
2,6,22.0,Hypersensitivity,16816048
0,1,22.0,Diarrhoea,16816127
1,6,22.0,Product use in unapproved indication,16816127
0,6,22.1,Aortitis,16816146
0,6,22.0,Malignant neoplasm progression,16816253
1,6,22.0,Drug ineffective,16816253
0,,22.1,Gastrooesophageal reflux disease,16816776
0,1,22.0,Neutropenia,16817035
1,6,22.0,Platelet count decreased,16817035
2,5,22.0,Lung disorder,16817035
0,6,22.0,Adverse event,16817090
0,3,22.0,Fatigue,16817111
0,6,22.1,Prescribed underdose,16817122
1,6,22.1,Device related infection,16817122
0,6,22.0,Central nervous system haemorrhage,16817123
1,6,22.0,Breast cancer metastatic,16817123
2,6,22.0,Off label use,16817123
0,6,22.0,Metastases to bone,16817135
1,6,22.0,Pneumonitis,16817135
2,6,22.0,Hospitalisation,16817135
3,6,22.0,Off label use,16817135
0,6,22.0,Malignant neoplasm progression,16817162
0,2,22.1,Plasma cell myeloma,16817163
1,1,22.1,Acute kidney injury,16817163
2,1,22.1,Feeling abnormal,16817163
0,5,22.1,Testis cancer,16817185
1,6,22.1,Neuropathy peripheral,16817185
0,6,22.0,Pleural effusion,16817190
1,5,22.0,Disease progression,16817190
2,6,22.0,Pulmonary embolism,16817190
3,6,22.0,Pneumonia,16817190
0,3,22.0,Febrile neutropenia,16817197
1,3,22.0,Therapy non-responder,16817197
0,1,22.1,Dry skin,16817251
1,1,22.1,Alopecia,16817251
2,3,22.1,Dizziness,16817251
3,3,22.1,Paraesthesia,16817251
4,1,22.1,Diarrhoea,16817251
5,1,22.1,Neutropenia,16817251
6,1,22.1,Leukopenia,16817251
7,1,22.1,Stomatitis,16817251
8,1,22.1,Anaemia,16817251
9,3,22.1,Fatigue,16817251
10,1,22.1,Dermatitis acneiform,16817251
0,1,22.1,Adrenal insufficiency,16817263
1,1,22.1,Atrial fibrillation,16817263
0,6,22.0,Product use in unapproved indication,16817275
1,5,22.0,Death,16817275
0,1,22.0,Neutropenia,16817277
0,6,22.1,Anxiety,16817301
1,6,22.1,Product dose omission,16817301
0,6,22.0,Dyspnoea,16817336
0,6,22.0,Asthenia,16817343
1,6,22.0,Headache,16817343
2,6,22.0,Drug reaction with eosinophilia and systemic symptoms,16817343
0,6,22.0,Intravascular haemolysis,16817380
1,6,22.0,Acute kidney injury,16817380
2,6,22.0,Autoimmune haemolytic anaemia,16817380
0,3,22.0,Cerebrovascular accident,16817399
1,2,22.0,Decreased appetite,16817399
2,3,22.0,Fatigue,16817399
3,3,22.0,Blood pressure increased,16817399
4,1,22.0,Nausea,16817399
5,3,22.0,Vomiting,16817399
6,1,22.0,Diarrhoea,16817399
0,1,22.1,Feeling abnormal,16817408
1,3,22.1,Headache,16817408
2,6,22.1,Muscle spasms,16817408
3,6,22.1,Diabetes mellitus,16817408
4,6,22.1,Memory impairment,16817408
5,6,22.1,Disturbance in attention,16817408
6,6,22.1,Pain,16817408
7,6,22.1,Arthralgia,16817408
8,2,22.1,Diarrhoea,16817408
9,6,22.1,Balance disorder,16817408
10,6,22.1,Fall,16817408
11,6,22.1,Pleural effusion,16817408
12,6,22.1,Stress,16817408
13,6,22.1,Depressed mood,16817408
14,6,22.1,Neoplasm progression,16817408
0,6,22.1,Bone pain,16817413
1,6,22.1,Flushing,16817413
2,6,22.1,Osteopenia,16817413
3,6,22.1,Neoplasm progression,16817413
0,6,22.1,Alopecia,16817414
1,6,22.1,White blood cell count decreased,16817414
2,6,22.1,Product dose omission,16817414
3,6,22.1,Dry skin,16817414
4,6,22.1,Anaemia,16817414
5,6,22.1,Memory impairment,16817414
0,6,22.1,Rib fracture,16817456
1,3,22.1,Visual impairment,16817456
2,6,22.1,Malaise,16817456
3,6,22.1,Neoplasm progression,16817456
4,6,22.1,Cognitive disorder,16817456
0,1,22.1,Hypothyroidism,16817520
1,1,22.1,Hypertension,16817520
2,3,22.1,Haemoptysis,16817520
0,6,22.0,Fluid intake reduced,16817564
0,6,22.0,Rash,16817577
1,6,22.0,Nausea,16817577
2,6,22.0,Contusion,16817577
0,,22.1,Death,16817590
0,6,22.1,Dysstasia,16817593
1,6,22.1,Pain,16817593
2,6,22.1,Disturbance in attention,16817593
3,6,22.1,Cognitive disorder,16817593
4,6,22.1,Malaise,16817593
0,6,22.0,Product dose omission,16817635
1,6,22.0,No adverse event,16817635
2,6,22.0,Product quality issue,16817635
3,6,22.0,Circumstance or information capable of leading to medication error,16817635
0,,22.1,Disease progression,16817665
0,6,22.0,Dysphonia,16817686
0,3,22.0,Blood pressure increased,16817768
0,1,22.0,Neutropenia,16817788
0,1,22.0,Rash erythematous,16817810
1,1,22.0,Skin lesion,16817810
0,2,22.0,General physical health deterioration,16817817
1,2,22.0,Confusional state,16817817
2,2,22.0,Fatigue,16817817
0,3,22.0,Movement disorder,16817819
1,6,22.0,Change of bowel habit,16817819
2,2,22.0,Nausea,16817819
3,6,22.0,Product dose omission,16817819
4,6,22.0,Procedural pain,16817819
5,2,22.0,Vomiting,16817819
6,6,22.0,Nausea,16817819
7,6,22.0,Pain,16817819
8,6,22.0,Pain in extremity,16817819
9,6,22.0,Vitamin D decreased,16817819
10,6,22.0,Disturbance in attention,16817819
11,6,22.0,Blood potassium abnormal,16817819
12,6,22.0,Dizziness,16817819
13,6,22.0,Tearfulness,16817819
14,6,22.0,Feeling abnormal,16817819
15,6,22.0,Fatigue,16817819
16,6,22.0,Abdominal pain,16817819
17,6,22.0,Arthralgia,16817819
18,6,22.0,Hepatic neoplasm,16817819
19,6,22.0,Constipation,16817819
20,6,22.0,Malaise,16817819
21,6,22.0,Tooth disorder,16817819
22,6,22.0,Apathy,16817819
23,6,22.0,Gastrooesophageal reflux disease,16817819
24,6,22.0,Decreased activity,16817819
25,6,22.0,Procedural pain,16817819
26,6,22.0,Pain in extremity,16817819
27,6,22.0,Hypertension,16817819
28,6,22.0,Swelling,16817819
0,,22.0,Hepatocellular injury,16817820
0,6,22.0,Off label use,16817840
1,6,22.0,Hypertension,16817840
2,6,22.0,Product use in unapproved indication,16817840
0,2,22.0,Haemoglobin decreased,16817887
1,2,22.0,Anaemia,16817887
2,2,22.0,Erythropoiesis abnormal,16817887
3,2,22.0,Bone marrow failure,16817887
0,3,22.1,Muscle spasms,16817890
1,3,22.1,Injection site oedema,16817890
2,6,22.1,Muscle atrophy,16817890
3,2,22.1,Injection site erythema,16817890
4,6,22.1,Off label use,16817890
5,6,22.1,Weight decreased,16817890
6,3,22.1,Injection site induration,16817890
0,1,22.1,Headache,16817928
1,1,22.1,Paraesthesia,16817928
2,1,22.1,Constipation,16817928
3,1,22.1,Labyrinthitis,16817928
4,1,22.1,Hypokalaemia,16817928
5,1,22.1,Influenza like illness,16817928
6,1,22.1,Hypersensitivity,16817928
7,1,22.1,Rash,16817928
8,1,22.1,Muscle spasms,16817928
9,1,22.1,Arthralgia,16817928
10,1,22.1,Upper respiratory tract infection,16817928
11,1,22.1,Gastrooesophageal reflux disease,16817928
12,6,22.1,Alopecia,16817928
13,1,22.1,Dizziness,16817928
14,1,22.1,Fatigue,16817928
15,1,22.1,Paronychia,16817928
16,1,22.1,Dry eye,16817928
17,1,22.1,Diarrhoea,16817928
0,6,22.1,Polyneuropathy,16817977
1,6,22.1,Cardiac failure,16817977
2,6,22.1,Respiratory failure,16817977
3,6,22.1,Blood pressure increased,16817977
4,6,22.1,Haematoma,16817977
5,6,22.1,Pulmonary embolism,16817977
6,6,22.1,Pulmonary oedema,16817977
7,6,22.1,Chest discomfort,16817977
8,6,22.1,Dyspnoea,16817977
9,6,22.1,Immunodeficiency,16817977
10,6,22.1,Pleural effusion,16817977
11,6,22.1,Acute myocardial infarction,16817977
12,6,22.1,Carotid arteriosclerosis,16817977
13,6,22.1,Asthenia,16817977
14,6,22.1,Leukopenia,16817977
15,3,22.1,Invasive ductal breast carcinoma,16817977
16,6,22.1,Ejection fraction decreased,16817977
17,6,22.1,Drug intolerance,16817977
18,6,22.1,Hypotension,16817977
19,6,22.1,Fatigue,16817977
20,6,22.1,Pericardial effusion,16817977
21,6,22.1,Pneumonia,16817977
22,6,22.1,Hepatic steatosis,16817977
23,6,22.1,Cough,16817977
24,6,22.1,Eczema,16817977
25,3,22.1,Breast cancer,16817977
0,5,22.0,Cancer pain,16818111
1,5,22.0,Hepatitis fulminant,16818111
0,6,22.0,Uterine disorder,16818189
1,6,22.0,Disease progression,16818189
0,1,22.1,Lung disorder,16818249
0,1,22.1,Lung disorder,16818251
0,1,22.1,Lung disorder,16818253
0,1,22.0,Bone marrow failure,16818258
0,1,22.1,Lung disorder,16818262
0,1,22.1,Weight decreased,16818277
0,6,22.0,Dizziness,16818278
1,1,22.0,Constipation,16818278
0,,22.0,Renal failure,16818290
1,6,22.0,Hospitalisation,16818290
0,6,22.0,Impaired quality of life,16818375
1,6,22.0,Anxiety,16818375
2,2,22.0,Alopecia,16818375
3,6,22.0,Pain,16818375
4,6,22.0,Psychological trauma,16818375
5,6,22.0,Emotional distress,16818375
0,6,22.1,Psychological trauma,16818386
1,6,22.1,Impaired quality of life,16818386
2,3,22.1,Alopecia,16818386
3,6,22.1,Emotional distress,16818386
4,6,22.1,Anxiety,16818386
5,6,22.1,Pain,16818386
0,6,22.1,Psychological trauma,16818478
1,3,22.1,Alopecia,16818478
0,3,22.0,Asthenia,16818549
1,3,22.0,Confusional state,16818549
2,3,22.0,Pain,16818549
3,,22.0,Off label use,16818549
4,3,22.0,Intentional dose omission,16818549
5,6,22.0,Product dose omission,16818549
6,5,22.0,Death,16818549
7,3,22.0,Mobility decreased,16818549
8,3,22.0,Decreased appetite,16818549
0,6,22.0,Intestinal obstruction,16818637
0,5,22.0,Death,16818648
0,6,22.0,Cardiac disorder,16818652
0,5,22.0,Malignant neoplasm progression,16818687
1,5,22.0,Bone cancer,16818687
2,5,22.0,Lung neoplasm malignant,16818687
0,6,22.0,Breast cancer,16818689
1,6,22.0,Metastases to liver,16818689
2,6,22.0,Malignant neoplasm progression,16818689
0,5,22.1,Prostate cancer,16818732
0,5,22.0,Neoplasm skin,16818738
0,6,22.0,Disease progression,16818742
0,1,22.1,Cardiac failure,16818753
1,2,22.1,Interstitial lung disease,16818753
0,5,22.0,Ileus,16818756
0,6,22.0,Acute myeloid leukaemia,16818760
0,5,22.1,Encephalitis,16818788
1,6,22.1,Metastases to central nervous system,16818788
0,6,22.1,Angiopathy,16818793
1,6,22.1,Carotid artery occlusion,16818793
0,1,22.0,Pleural effusion,16818843
0,2,22.1,Toxic epidermal necrolysis,16818850
1,2,22.1,Fatigue,16818850
2,2,22.1,Pyrexia,16818850
3,2,22.1,Dyspnoea,16818850
4,2,22.1,Rash,16818850
0,3,22.0,Blood count abnormal,16818864
0,6,22.0,Erysipelas,16818882
1,6,22.0,Haematotoxicity,16818882
0,5,22.0,Metastases to bone,16818907
1,5,22.0,Metastases to liver,16818907
2,5,22.0,Breast cancer metastatic,16818907
3,5,22.0,Metastases to lung,16818907
4,5,22.0,Metastases to skin,16818907
5,5,22.0,Malignant neoplasm progression,16818907
0,1,22.0,Nausea,16818920
1,1,22.0,Balance disorder,16818920
2,1,22.0,Vomiting,16818920
3,1,22.0,Paraesthesia,16818920
0,3,22.0,Thrombocytopenia,16818948
0,1,22.1,Hypoglycaemia,16818981
1,1,22.1,Lymphocyte count decreased,16818981
0,3,22.0,Alopecia,16818984
1,3,22.0,Hair texture abnormal,16818984
2,3,22.0,Hair colour changes,16818984
3,3,22.0,Hair disorder,16818984
0,3,22.0,Alopecia,16818990
1,3,22.0,Madarosis,16818990
2,3,22.0,Hair disorder,16818990
3,3,22.0,Hair texture abnormal,16818990
4,3,22.0,Hair colour changes,16818990
0,3,22.0,Appendicitis,16819076
1,6,22.0,Diarrhoea,16819076
0,6,22.0,Metastases to bone,16819107
1,6,22.0,Malignant neoplasm progression,16819107
2,6,22.0,Breast cancer metastatic,16819107
0,1,22.0,Oedema peripheral,16819113
1,3,22.0,Discomfort,16819113
2,3,22.0,Asthenia,16819113
3,1,22.0,Face oedema,16819113
0,4,22.1,Cerebrovascular accident,16819117
0,1,22.0,Hypoglycaemia,16819122
0,6,22.1,Malignant neoplasm progression,16819131
1,6,22.1,Haematuria,16819131
2,6,22.1,Pancreatic enzymes increased,16819131
3,6,22.1,Deep vein thrombosis,16819131
4,6,22.1,General physical health deterioration,16819131
5,5,22.1,Interstitial lung disease,16819131
6,5,22.1,Cardiac arrest,16819131
7,6,22.1,Urinary tract infection,16819131
8,6,22.1,Blood pressure decreased,16819131
9,5,22.1,Respiratory failure,16819131
10,1,22.1,Paronychia,16819131
0,3,22.1,Drug-induced liver injury,16819135
1,3,22.1,Hepatic failure,16819135
0,6,22.0,Hypothyroidism,16819146
1,6,22.0,Urine odour abnormal,16819146
2,6,22.0,Chromaturia,16819146
0,2,22.0,Blood pressure increased,16819152
1,2,22.0,Chills,16819152
2,2,22.0,Heart rate increased,16819152
3,2,22.0,Pyrexia,16819152
0,5,22.0,Interstitial lung disease,16819182
0,3,22.1,Coronary artery stenosis,16819231
0,5,22.0,Death,16819246
0,6,22.0,Feeling abnormal,16819271
1,6,22.0,Fatigue,16819271
0,6,22.0,Weight decreased,16819272
1,6,22.0,Decreased appetite,16819272
0,3,22.0,Thrombosis,16819382
0,6,22.1,Nausea,16819426
1,6,22.1,Blood sodium decreased,16819426
2,6,22.1,Blood magnesium decreased,16819426
3,6,22.1,Dehydration,16819426
4,6,22.1,Abdominal rigidity,16819426
5,6,22.1,Vomiting,16819426
6,6,22.1,Oedema,16819426
0,1,22.0,Acute coronary syndrome,16819450
1,1,22.0,Troponin increased,16819450
0,1,22.1,Anaemia,16819499
0,1,22.0,Gastrointestinal haemorrhage,16819501
1,6,22.0,Large intestinal ulcer,16819501
2,6,22.0,Product use in unapproved indication,16819501
0,6,22.0,Intestinal obstruction,16819537
1,6,22.0,Product use in unapproved indication,16819537
0,3,22.1,Diarrhoea,16819564
1,5,22.1,Malignant neoplasm progression,16819564
0,6,22.1,Pulmonary mass,16819571
1,6,22.1,Pain in extremity,16819571
2,6,22.1,Hypoaesthesia,16819571
3,6,22.1,Influenza,16819571
0,2,22.0,Diarrhoea,16819577
0,6,22.0,Acute myeloid leukaemia,16819583
0,5,22.0,Death,16819666
0,5,22.1,Malignant neoplasm progression,16819668
1,6,22.1,Dehydration,16819668
2,6,22.1,Thrombosis,16819668
0,1,22.0,Liver function test increased,16819676
0,1,22.0,Pneumonia,16819686
0,6,22.1,No adverse event,16819692
0,6,22.0,Off label use,16819693
1,5,22.0,Death,16819693
0,5,22.0,Death,16819694
0,6,22.0,Infection,16819695
0,6,22.0,Hyperkalaemia,16819697
0,2,22.1,Malignant neoplasm progression,16819715
1,6,22.1,Speech disorder,16819715
2,6,22.1,Amnesia,16819715
3,2,22.1,Breast cancer,16819715
4,6,22.1,Gait inability,16819715
5,6,22.1,Decreased appetite,16819715
6,6,22.1,Hypotonia,16819715
7,6,22.1,General physical health deterioration,16819715
8,6,22.1,Mobility decreased,16819715
9,2,22.1,Hydrocephalus,16819715
0,2,22.0,Gastrointestinal disorder,16819752
1,2,22.0,Decreased appetite,16819752
2,2,22.0,Atelectasis,16819752
3,2,22.0,Asthenia,16819752
4,2,22.0,Respiratory syncytial virus infection,16819752
5,2,22.0,Dyspnoea,16819752
6,2,22.0,Nausea,16819752
7,2,22.0,Respiratory failure,16819752
0,1,22.0,Agranulocytosis,16819806
1,1,22.0,Leukopenia,16819806
0,1,22.0,Agranulocytosis,16819807
1,1,22.0,Leukopenia,16819807
0,1,22.0,Leukopenia,16819808
1,1,22.0,Agranulocytosis,16819808
0,2,22.0,Leukopenia,16819810
1,2,22.0,Agranulocytosis,16819810
0,6,22.0,Dyspnoea,16819834
1,6,22.0,Oxygen saturation decreased,16819834
2,6,22.0,C-reactive protein increased,16819834
3,5,22.0,Death,16819834
4,6,22.0,Pyrexia,16819834
0,6,22.0,Haematotoxicity,16819839
0,2,22.0,Respiratory failure,16819850
1,2,22.0,Lymphangioleiomyomatosis,16819850
0,1,22.1,Nasal inflammation,16819870
1,6,22.1,Hypertension,16819870
2,1,22.1,Skin disorder,16819870
3,1,22.1,Rash,16819870
4,1,22.1,Dysuria,16819870
5,1,22.1,Leukopenia,16819870
6,1,22.1,Lacrimation increased,16819870
7,3,22.1,Visual impairment,16819870
8,1,22.1,Pain in extremity,16819870
9,1,22.1,Headache,16819870
10,1,22.1,Mucosal inflammation,16819870
11,1,22.1,Haemorrhoids,16819870
12,1,22.1,Erythema,16819870
0,6,22.0,IgA nephropathy,16819896
0,5,22.0,Cardiac arrest,16819935
0,6,22.0,Nasopharyngitis,16819956
1,6,22.0,Pneumonitis,16819956
2,5,22.0,Epilepsy,16819956
0,6,22.0,Constipation,16819987
0,1,22.1,Bladder dilatation,16819988
1,2,22.1,Urosepsis,16819988
2,6,22.1,Fall,16819988
3,2,22.1,Decubitus ulcer,16819988
4,6,22.1,Urinary tract obstruction,16819988
0,6,22.1,Cholangitis,16820203
0,3,22.0,Implant site pain,16820255
1,3,22.0,Osteonecrosis of jaw,16820255
0,6,22.1,Dehydration,16820295
1,6,22.1,Asthenia,16820295
2,6,22.1,Product dose omission,16820295
3,6,22.1,Constipation,16820295
0,4,22.0,Upper gastrointestinal haemorrhage,16820320
1,6,22.0,Chest pain,16820320
2,6,22.0,Anaemia,16820320
3,6,22.0,Acute coronary syndrome,16820320
0,5,22.0,Ileus,16820326
0,6,22.0,Cardiac dysfunction,16820331
0,1,22.0,Mucosal inflammation,16820381
0,1,22.0,Oesophagitis,16820403
0,1,22.0,Hyponatraemic seizure,16820541
1,1,22.0,Hyponatraemia,16820541
2,1,22.0,Postictal state,16820541
3,1,22.0,Blood osmolarity,16820541
0,6,22.1,Small intestinal perforation,16820569
0,5,22.0,Prostate cancer,16820612
1,6,22.0,Prescribed underdose,16820612
0,6,22.0,Malignant neoplasm progression,16820613
1,6,22.0,Gene mutation identification test,16820613
2,6,22.0,Skin toxicity,16820613
0,5,22.0,Death,16820617
0,6,22.1,Oedema,16820653
0,1,22.0,Malaise,16820697
1,1,22.0,Hypotension,16820697
2,3,22.0,Fatigue,16820697
3,1,22.0,Asthenia,16820697
4,6,22.0,Product use issue,16820697
0,5,22.0,Death,16820740
0,6,22.0,Hyperglycaemia,16820755
0,6,22.0,Hepatic neoplasm,16820784
0,1,22.0,Eczema,16820807
1,1,22.0,Interstitial lung disease,16820807
0,6,22.0,C-reactive protein abnormal,16820821
1,6,22.0,Pyrexia,16820821
2,6,22.0,Lethargy,16820821
3,5,22.0,Death,16820821
4,6,22.0,Dyspnoea,16820821
0,2,22.1,Rash,16820849
0,6,22.1,Small intestinal perforation,16820863
1,1,22.1,Myositis,16820863
2,6,22.1,Enteritis,16820863
0,3,22.0,Jaundice cholestatic,16820898
1,6,22.0,Faeces pale,16820898
2,6,22.0,Chromaturia,16820898
3,6,22.0,Liver injury,16820898
4,6,22.0,Fatigue,16820898
0,6,22.0,Gastric disorder,16821028
1,6,22.0,Abdominal distension,16821028
0,6,22.0,Eye disorder,16821050
0,1,22.1,Increased appetite,16821066
1,1,22.1,Malaise,16821066
2,3,22.1,Alopecia,16821066
3,1,22.1,Platelet count decreased,16821066
4,2,22.1,Carbohydrate antigen 125 increased,16821066
5,1,22.1,Nervousness,16821066
6,6,22.1,Grip strength decreased,16821066
7,6,22.1,Intentional underdose,16821066
8,2,22.1,Bronchitis,16821066
9,1,22.1,Abdominal pain upper,16821066
10,6,22.1,Emotional distress,16821066
11,1,22.1,Performance status decreased,16821066
12,3,22.1,Dizziness,16821066
13,1,22.1,Constipation,16821066
14,6,22.1,Vomiting,16821066
15,6,22.1,Heat stroke,16821066
16,3,22.1,Neuropathy peripheral,16821066
17,3,22.1,Fatigue,16821066
18,1,22.1,Insomnia,16821066
19,3,22.1,Nausea,16821066
20,3,22.1,Asthenia,16821066
0,6,22.0,Vomiting,16821080
1,6,22.0,Hepatic function abnormal,16821080
2,6,22.0,Bone marrow failure,16821080
3,6,22.0,Nausea,16821080
0,2,22.1,Hyperglycaemia,16821083
0,6,22.0,Acute myeloid leukaemia,16821135
0,1,22.0,Hypotension,16821140
1,1,22.0,Sense of oppression,16821140
2,1,22.0,Dyspnoea,16821140
0,3,22.0,Drug resistance,16821173
1,6,22.0,Malignant neoplasm progression,16821173
2,6,22.0,Hyperhidrosis,16821173
0,6,22.0,Diarrhoea,16821224
1,1,22.0,Interstitial lung disease,16821224
2,1,22.0,Septic shock,16821224
3,1,22.0,Pancreatitis,16821224
4,1,22.0,Colitis,16821224
0,6,22.0,Product odour abnormal,16821231
1,1,22.0,Depression,16821231
2,1,22.0,Metabolic disorder,16821231
3,6,22.0,Product use in unapproved indication,16821231
0,3,22.0,Skin infection,16821233
1,3,22.0,Staphylococcal infection,16821233
0,2,22.1,Blood creatinine increased,16821263
0,2,22.0,Leukopenia,16821270
1,2,22.0,Neutropenia,16821270
0,5,22.0,Pulmonary fibrosis,16821279
0,3,22.0,Neuropathy peripheral,16821308
0,6,22.0,Pleural effusion,16821357
1,1,22.0,Dyspnoea,16821357
2,1,22.0,Pyrexia,16821357
3,2,22.0,Decreased appetite,16821357
4,3,22.0,Fatigue,16821357
5,6,22.0,Pulmonary congestion,16821357
6,6,22.0,Concomitant disease aggravated,16821357
7,3,22.0,Vaginal haemorrhage,16821357
8,3,22.0,Abdominal pain lower,16821357
9,6,22.0,Blood magnesium decreased,16821357
0,,22.1,Infection,16821370
1,,22.1,Therapy cessation,16821370
0,,22.1,Hospice care,16821372
0,3,22.1,Diabetic metabolic decompensation,16821424
0,5,22.0,Pneumonitis,16821439
0,6,22.0,Product use in unapproved indication,16821514
1,6,22.0,Off label use,16821514
2,5,22.0,Death,16821514
0,6,22.1,Condition aggravated,16821522
1,6,22.1,Muscle strain,16821522
2,6,22.1,Haemoglobin decreased,16821522
3,6,22.1,Thrombocytopenia,16821522
4,6,22.1,Febrile neutropenia,16821522
5,6,22.1,Mucosal inflammation,16821522
6,6,22.1,Cytopenia,16821522
7,6,22.1,Neutropenia,16821522
8,6,22.1,Otitis externa,16821522
9,6,22.1,Lactose intolerance,16821522
10,6,22.1,Pain,16821522
11,6,22.1,Hypotension,16821522
12,6,22.1,Fatigue,16821522
0,5,22.0,Death,16821523
0,5,22.0,Death,16821530
1,6,22.0,Neoplasm progression,16821530
0,3,22.0,Neoplasm progression,16821541
1,6,22.0,Neutropenia,16821541
0,5,22.0,Death,16821547
0,,22.1,Disease progression,16821550
0,3,22.0,Abdominal pain,16821558
1,3,22.0,Nephrolithiasis,16821558
0,6,22.0,Immune-mediated adverse reaction,16821612
1,6,22.0,Organising pneumonia,16821612
0,1,22.0,Capillary leak syndrome,16821653
0,1,22.1,Blood disorder,16821661
0,5,22.1,Metastases to liver,16821690
1,6,22.1,Liver abscess,16821690
0,5,22.0,Death,16821736
1,6,22.0,Intestinal obstruction,16821736
0,2,22.1,Urinary tract infection,16821758
1,3,22.1,Dizziness,16821758
2,3,22.1,Decreased appetite,16821758
3,2,22.1,Cystitis,16821758
4,3,22.1,Asthenia,16821758
5,3,22.1,Hot flush,16821758
6,6,22.1,Discomfort,16821758
0,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,16821795
1,6,22.1,Fatigue,16821795
2,2,22.1,Cognitive disorder,16821795
3,6,22.1,Neutropenia,16821795
4,6,22.1,Leukopenia,16821795
5,1,22.1,Nausea,16821795
0,6,22.0,Essential hypertension,16821834
1,6,22.0,Osteoporosis,16821834
2,6,22.0,Diabetes mellitus,16821834
3,6,22.0,Type IIa hyperlipidaemia,16821834
4,6,22.0,White blood cell count decreased,16821834
5,6,22.0,Cataract,16821834
6,6,22.0,Neoplasm progression,16821834
7,6,22.0,Vitamin D deficiency,16821834
8,6,22.0,Back pain,16821834
0,6,22.0,Product use in unapproved indication,16821856
1,6,22.0,Bone pain,16821856
2,6,22.0,Hepatomegaly,16821856
3,6,22.0,Off label use,16821856
4,6,22.0,Neutropenia,16821856
0,1,22.1,Hypocalcaemia,16821970
0,1,22.0,Pulmonary embolism,16821977
1,6,22.0,Off label use,16821977
0,6,22.0,Polyneuropathy,16821981
0,2,22.1,Urinary tract infection,16821982
1,2,22.1,Skin disorder,16821982
2,6,22.1,Drug ineffective,16821982
3,2,22.1,Skin haemorrhage,16821982
0,6,22.0,Adverse event,16821988
0,4,22.1,Thrombotic cerebral infarction,16821991
0,6,22.0,Febrile neutropenia,16822009
0,,22.1,Death,16822127
0,,22.1,Rash,16822145
0,,22.1,Hospitalisation,16822147
0,3,22.1,Radiation pneumonitis,16822148
1,6,22.1,Nocturia,16822148
2,4,22.1,Autoimmune thyroiditis,16822148
3,4,22.1,Hyperthyroidism,16822148
4,6,22.1,Silent thyroiditis,16822148
0,6,22.0,Off label use,16822154
1,6,22.0,Drug ineffective for unapproved indication,16822154
0,6,22.1,Neoplasm progression,16822176
1,6,22.1,Memory impairment,16822176
2,6,22.1,Fatigue,16822176
3,6,22.1,Disturbance in attention,16822176
0,3,22.0,Skin exfoliation,16822210
1,3,22.0,Glossodynia,16822210
2,3,22.0,Oral pain,16822210
3,6,22.0,Gallbladder disorder,16822210
4,3,22.0,Pain in extremity,16822210
5,6,22.0,Decreased appetite,16822210
6,6,22.0,Tooth disorder,16822210
7,6,22.0,Blood pressure increased,16822210
8,3,22.0,Hyperkeratosis,16822210
9,3,22.0,Food allergy,16822210
10,6,22.0,Weight decreased,16822210
11,3,22.0,Diarrhoea,16822210
0,5,22.0,Breast cancer metastatic,16822226
1,6,22.0,General physical health deterioration,16822226
0,,22.1,Bladder neoplasm surgery,16822232
1,,22.1,Blood count abnormal,16822232
2,,22.1,Therapy cessation,16822232
0,3,22.0,Lung disorder,16822235
1,1,22.0,Cardiac valve disease,16822235
0,,22.1,Hospice care,16822245
1,,22.1,Disease progression,16822245
0,,22.1,Disease progression,16822249
0,6,22.1,Prostatic specific antigen increased,16822251
1,6,22.1,Rib fracture,16822251
2,6,22.1,Vital functions abnormal,16822251
3,3,22.1,Hot flush,16822251
4,3,22.1,Epistaxis,16822251
5,6,22.1,Fall,16822251
6,6,22.1,Diverticulitis,16822251
7,6,22.1,Pain,16822251
0,,22.1,Dehydration,16822252
1,,22.1,Malaise,16822252
2,,22.1,Therapy cessation,16822252
0,,22.1,Death,16822256
0,6,22.0,Malaise,16822262
0,6,22.0,Neoplasm progression,16822263
0,6,22.1,Off label use,16822269
1,6,22.1,Leukopenia,16822269
2,6,22.1,Product use in unapproved indication,16822269
0,6,22.0,Neoplasm progression,16822274
1,6,22.0,Abdominal pain lower,16822274
0,6,22.1,Anosmia,16822290
1,6,22.1,Madarosis,16822290
2,6,22.1,Dizziness postural,16822290
3,6,22.1,Alopecia,16822290
4,6,22.1,Asthenia,16822290
5,6,22.1,Eating disorder,16822290
6,6,22.1,Blood count abnormal,16822290
7,6,22.1,Ageusia,16822290
8,6,22.1,Dry skin,16822290
9,6,22.1,Red blood cell count decreased,16822290
10,6,22.1,Pruritus,16822290
11,6,22.1,Fatigue,16822290
12,6,22.1,Irritability,16822290
13,6,22.1,Eye pruritus,16822290
14,6,22.1,Chills,16822290
15,6,22.1,Constipation,16822290
16,6,22.1,Taste disorder,16822290
0,,22.1,Renal failure,16822292
1,,22.1,Dialysis,16822292
0,,22.1,Skin burning sensation,16822303
1,,22.1,Myalgia,16822303
0,6,22.1,Feeling abnormal,16822308
0,,22.1,Stomatitis,16822318
1,,22.1,Diarrhoea,16822318
0,,22.1,Disease progression,16822347
1,,22.1,Therapy cessation,16822347
0,2,22.1,Nausea,16822435
1,6,22.1,Paraesthesia,16822435
2,2,22.1,Alopecia,16822435
3,6,22.1,Intentional product misuse,16822435
4,1,22.1,Vomiting,16822435
0,6,22.0,Headache,16822442
1,6,22.0,Hot flush,16822442
2,6,22.0,Fatigue,16822442
0,6,22.1,Headache,16822451
0,6,22.1,Neoplasm progression,16822454
1,6,22.1,Aphasia,16822454
2,6,22.1,Lacrimal disorder,16822454
3,6,22.1,Eyelid pain,16822454
4,6,22.1,Eye pain,16822454
0,2,22.0,Drug ineffective for unapproved indication,16822455
1,2,22.0,Off label use,16822455
0,5,22.0,Death,16822539
0,6,22.1,Platelet count decreased,16822592
1,6,22.1,Neutropenia,16822592
0,1,22.0,White blood cell count decreased,16822640
1,1,22.0,Agranulocytosis,16822640
0,6,22.0,Fatigue,16822644
0,6,22.1,White blood cell count decreased,16822649
0,6,22.1,Abdominal discomfort,16822650
1,2,22.1,Nausea,16822650
0,1,22.0,Hydrothorax,16822728
1,1,22.0,Leiomyoma,16822728
2,1,22.0,Metastases to lung,16822728
3,1,22.0,Dizziness,16822728
4,1,22.0,Breast cancer,16822728
5,1,22.0,Metastases to lymph nodes,16822728
6,1,22.0,Metastases to the mediastinum,16822728
7,1,22.0,Metastases to bone,16822728
8,1,22.0,Hypertension,16822728
9,6,22.0,Dyspnoea,16822728
10,1,22.0,Fatigue,16822728
11,1,22.0,Metastases to pleura,16822728
12,6,22.0,Pleural effusion,16822728
0,6,22.0,Xerophthalmia,16822743
1,6,22.0,Back pain,16822743
2,6,22.0,Asthenia,16822743
3,6,22.0,Dry eye,16822743
0,3,22.1,Disorientation,16822797
1,3,22.1,Psychomotor retardation,16822797
2,3,22.1,General physical health deterioration,16822797
3,5,22.1,Neoplasm progression,16822797
0,,22.1,Therapy cessation,16822798
1,,22.1,Surgery,16822798
0,,22.1,Hospitalisation,16822801
0,6,22.0,Defaecation urgency,16822822
1,6,22.0,Dry skin,16822822
2,6,22.0,Abdominal pain upper,16822822
3,2,22.0,Pleural effusion,16822822
4,3,22.0,Diarrhoea,16822822
5,2,22.0,Dyspnoea,16822822
6,6,22.0,Nausea,16822822
7,3,22.0,Fatigue,16822822
0,2,22.0,Neutropenia,16822839
1,2,22.0,Leukopenia,16822839
0,1,22.1,Ileus,16822944
0,6,22.0,Metastasis,16822975
1,6,22.0,Malignant neoplasm progression,16822975
2,6,22.0,Large intestinal obstruction,16822975
3,6,22.0,Intestinal mass,16822975
0,3,22.0,Blood creatinine increased,16823061
1,3,22.0,Dehydration,16823061
2,3,22.0,Nausea,16823061
3,3,22.0,Vomiting,16823061
0,6,22.0,Pulmonary embolism,16823126
0,3,22.1,Blood magnesium decreased,16823183
1,3,22.1,Pain in extremity,16823183
2,3,22.1,Pruritus,16823183
3,3,22.1,Alopecia,16823183
4,3,22.1,Neuropathy peripheral,16823183
5,3,22.1,Rosacea,16823183
6,3,22.1,Adverse event,16823183
0,3,22.1,Adrenal insufficiency,16823295
0,2,22.0,Diarrhoea,16823324
1,3,22.0,Mouth ulceration,16823324
2,3,22.0,Burn oral cavity,16823324
3,2,22.0,Hyperaesthesia,16823324
4,2,22.0,Hyperaesthesia,16823324
5,3,22.0,Nausea,16823324
6,3,22.0,Alopecia,16823324
7,3,22.0,Abdominal pain upper,16823324
8,2,22.0,Dry skin,16823324
9,2,22.0,Constipation,16823324
10,3,22.0,Oral pain,16823324
0,5,22.0,Renal cancer metastatic,16823337
1,1,22.0,Confusional state,16823337
2,1,22.0,Hallucination,16823337
3,3,22.0,Pruritus,16823337
4,3,22.0,Purpura,16823337
5,3,22.0,Eosinophilia,16823337
6,3,22.0,Oedema,16823337
0,6,22.0,Dry eye,16823338
1,6,22.0,Malignant neoplasm progression,16823338
0,3,22.0,Dehydration,16823363
1,3,22.0,Urinary tract infection,16823363
0,6,22.1,Rash erythematous,16823421
0,6,22.0,Fatigue,16823457
1,6,22.0,Vertigo,16823457
2,6,22.0,Gait disturbance,16823457
3,6,22.0,Dizziness,16823457
4,6,22.0,Hemiparesis,16823457
0,3,22.0,Vitreous floaters,16823465
1,3,22.0,Visual impairment,16823465
2,3,22.0,Photosensitivity reaction,16823465
0,5,22.1,Myocardial infarction,16823467
0,3,22.0,Spinal pain,16823469
1,3,22.0,Chest pain,16823469
2,3,22.0,Back pain,16823469
0,5,22.0,Death,16823514
0,5,22.0,Death,16823515
0,2,22.1,Leukopenia,16823534
1,2,22.1,Blood creatinine increased,16823534
0,1,22.0,Hyponatraemia,16823540
1,1,22.0,Hyperglycaemia,16823540
0,5,22.0,Death,16823559
0,3,22.1,Madarosis,16823576
1,3,22.1,Hair colour changes,16823576
2,3,22.1,Alopecia,16823576
3,3,22.1,Hair texture abnormal,16823576
4,3,22.1,Hair disorder,16823576
0,5,22.0,Death,16823578
0,1,22.0,Leukopenia,16823579
1,1,22.0,Agranulocytosis,16823579
0,1,22.0,Leukopenia,16823583
1,1,22.0,Agranulocytosis,16823583
0,6,22.0,Leukopenia,16823584
0,1,22.0,Hypophagia,16823591
1,1,22.0,Decreased appetite,16823591
2,1,22.0,Vomiting,16823591
3,1,22.0,Nausea,16823591
0,1,22.0,Agranulocytosis,16823592
1,1,22.0,Leukopenia,16823592
0,1,22.0,Agranulocytosis,16823593
0,1,22.0,Leukopenia,16823594
0,1,22.0,Agranulocytosis,16823595
0,3,22.1,Madarosis,16823609
1,3,22.1,Alopecia,16823609
2,3,22.1,Hair texture abnormal,16823609
3,3,22.1,Hair disorder,16823609
4,3,22.1,Hair colour changes,16823609
0,1,22.0,Interstitial lung disease,16823613
1,6,22.0,Drug interaction,16823613
0,3,22.1,Hypothyroidism,16823635
1,1,22.1,Dermatitis bullous,16823635
2,1,22.1,Pruritus,16823635
3,1,22.1,Radiation pneumonitis,16823635
0,2,22.1,Alopecia,16823698
1,6,22.1,Anxiety,16823698
2,6,22.1,Emotional distress,16823698
3,6,22.1,Impaired quality of life,16823698
4,6,22.1,Pain,16823698
5,6,22.1,Psychological trauma,16823698
0,2,22.0,Alopecia,16823703
1,6,22.0,Psychological trauma,16823703
0,2,22.0,Alopecia,16823731
1,6,22.0,Psychological trauma,16823731
0,6,22.1,Anxiety,16823757
1,6,22.1,Pain,16823757
2,2,22.1,Alopecia,16823757
3,6,22.1,Emotional distress,16823757
4,6,22.1,Impaired quality of life,16823757
0,1,22.0,Interstitial lung disease,16823798
1,1,22.0,Eczema,16823798
0,1,22.1,Hypokalaemia,16823809
1,1,22.1,Blood magnesium decreased,16823809
2,1,22.1,Blood calcium decreased,16823809
3,3,22.1,Infection,16823809
4,,22.1,Off label use,16823809
5,6,22.1,Colon cancer,16823809
0,1,22.0,Pulmonary oedema,16823825
1,3,22.0,Cardiac failure,16823825
0,6,22.0,Drug resistance,16823827
1,6,22.0,Malignant neoplasm progression,16823827
0,6,22.0,Acute kidney injury,16823829
1,6,22.0,Intravascular haemolysis,16823829
2,6,22.0,Haemoglobinuria,16823829
0,3,22.1,Bone marrow failure,16823837
0,3,22.0,Oedema peripheral,16823840
1,3,22.0,Asthma,16823840
0,3,22.1,Disease progression,16823877
0,3,22.0,Blood bilirubin increased,16823881
1,,22.0,Off label use,16823881
2,3,22.0,Adverse drug reaction,16823881
0,6,22.0,Cystitis,16823882
1,3,22.0,Asthenia,16823882
2,1,22.0,Nausea,16823882
3,1,22.0,Vomiting,16823882
4,,22.0,Off label use,16823882
5,6,22.0,Sepsis,16823882
6,3,22.0,Fatigue,16823882
7,1,22.0,Diarrhoea,16823882
0,6,22.0,Platelet count decreased,16823883
1,5,22.0,Death,16823883
0,6,22.0,Pulmonary fibrosis,16823884
1,6,22.0,Lung infiltration,16823884
0,5,22.1,Sepsis,16823894
1,6,22.1,Gastrointestinal haemorrhage,16823894
2,6,22.1,Myocardial infarction,16823894
3,6,22.1,Haemoglobin decreased,16823894
4,6,22.1,Neoplasm progression,16823894
0,2,22.1,Hyperglycaemia,16823968
0,4,22.0,Noninfective encephalitis,16823979
0,3,22.0,Hepatic encephalopathy,16824000
1,3,22.0,Bone pain,16824000
2,3,22.0,Hypertension,16824000
3,3,22.0,Nausea,16824000
4,3,22.0,Decreased appetite,16824000
5,3,22.0,Vomiting,16824000
0,6,22.0,Adverse event,16824021
0,3,22.1,Nausea,16824031
1,3,22.1,Peripheral swelling,16824031
2,3,22.1,Blood lactate dehydrogenase increased,16824031
3,3,22.1,Flushing,16824031
4,3,22.1,Pulmonary oedema,16824031
5,3,22.1,Rash,16824031
6,3,22.1,Hepatic enzyme increased,16824031
7,3,22.1,Hypersensitivity,16824031
8,3,22.1,Infusion related reaction,16824031
9,3,22.1,Malignant neoplasm progression,16824031
10,3,22.1,Ejection fraction,16824031
11,3,22.1,Epistaxis,16824031
12,3,22.1,Gamma-glutamyltransferase increased,16824031
13,3,22.1,Ill-defined disorder,16824031
14,3,22.1,Pneumonia,16824031
15,3,22.1,Asthenopia,16824031
16,3,22.1,Alanine aminotransferase increased,16824031
17,3,22.1,Blood alkaline phosphatase increased,16824031
18,3,22.1,Blood pressure increased,16824031
19,3,22.1,Metastases to lymph nodes,16824031
20,3,22.1,Pulmonary mass,16824031
21,3,22.1,Aspartate aminotransferase increased,16824031
22,3,22.1,Fatigue,16824031
23,3,22.1,Metastases to bone,16824031
24,3,22.1,Nasopharyngitis,16824031
0,6,22.0,Malignant neoplasm progression,16824036
1,6,22.0,Rheumatoid arthritis,16824036
0,2,22.1,Cholangitis sclerosing,16824056
1,1,22.1,Malaise,16824056
0,6,22.0,Medication error,16824075
1,3,22.0,Fall,16824075
2,6,22.0,Off label use,16824075
0,1,22.0,Metastases to eye,16824155
1,6,22.0,Metastases to central nervous system,16824155
2,1,22.0,Hypertension,16824155
3,1,22.0,Diabetes mellitus,16824155
4,1,22.0,Hypercholesterolaemia,16824155
0,6,22.1,Prostatic specific antigen increased,16824226
1,3,22.1,Prostate cancer,16824226
2,6,22.1,Metastases to bone,16824226
3,3,22.1,Hot flush,16824226
4,6,22.1,Metastases to lymph nodes,16824226
0,1,22.0,Prostatic specific antigen increased,16824240
1,6,22.0,Paraneoplastic syndrome,16824240
2,3,22.0,Neuropathy peripheral,16824240
0,6,22.0,Terminal state,16824263
0,6,22.0,Malignant neoplasm progression,16824288
1,6,22.0,Drug resistance,16824288
2,6,22.0,Hyperhidrosis,16824288
0,6,22.0,General physical health deterioration,16824296
1,5,22.0,Death,16824296
0,1,22.1,Pain,16824371
0,1,22.1,Interstitial lung disease,16824383
1,6,22.1,Respiratory failure,16824383
2,2,22.1,Mitral valve incompetence,16824383
3,6,22.1,Cardiac failure acute,16824383
0,1,22.1,Pyrexia,16824401
0,6,22.1,Diarrhoea,16824411
1,5,22.1,Interstitial lung disease,16824411
0,2,22.0,Seizure,16824532
0,6,22.0,Deep vein thrombosis,16824620
1,6,22.0,Cervical vertebral fracture,16824620
2,6,22.0,Metastases to the mediastinum,16824620
3,1,22.0,Pleural effusion,16824620
4,6,22.0,Metastases to bone,16824620
0,6,22.0,Diverticulitis,16824641
1,6,22.0,Wrist fracture,16824641
2,6,22.0,Back disorder,16824641
3,6,22.0,Gastrooesophageal reflux disease,16824641
4,6,22.0,Fall,16824641
5,6,22.0,Barrett^s oesophagus,16824641
6,6,22.0,Nephrolithiasis,16824641
7,6,22.0,Breast cancer metastatic,16824641
8,6,22.0,Uterine disorder,16824641
9,6,22.0,Disease progression,16824641
10,3,22.0,Osteopenia,16824641
11,6,22.0,Uterine cancer,16824641
0,2,22.1,Thyroiditis,16824664
1,2,22.1,Orthostatic hypotension,16824664
0,1,22.0,Dehydration,16824684
0,6,22.0,Jaundice,16824685
1,6,22.0,Off label use,16824685
0,5,22.0,Death,16824749
1,6,22.0,Malaise,16824749
0,6,22.0,Wound,16824760
0,5,22.0,Death,16824772
0,3,22.0,Nausea,16824776
1,1,22.0,Diarrhoea,16824776
2,3,22.0,Decreased appetite,16824776
3,6,22.0,Product use issue,16824776
4,1,22.0,Vomiting,16824776
5,1,22.0,Blood phosphorus decreased,16824776
0,1,22.0,Leukopenia,16824785
1,1,22.0,Agranulocytosis,16824785
0,1,22.1,Rheumatoid arthritis,16824787
0,5,22.0,Malignant neoplasm progression,16824789
1,5,22.0,Lung infection,16824789
0,2,22.1,Chills,16824878
1,2,22.1,Pyrexia,16824878
2,2,22.1,Palpitations,16824878
0,2,22.0,Blood bilirubin increased,16824884
0,2,22.0,Leukopenia,16824886
1,2,22.0,Agranulocytosis,16824886
0,6,22.1,Pruritus,16824902
1,6,22.1,Rash,16824902
2,6,22.1,Diarrhoea,16824902
3,6,22.1,Fatigue,16824902
0,1,22.0,Infection,16824934
1,1,22.0,Pancytopenia,16824934
0,3,22.0,Adenocarcinoma,16825000
1,6,22.0,Drug ineffective,16825000
2,3,22.0,Metastasis,16825000
3,1,22.0,Bone pain,16825000
0,5,22.0,Hepatic enzyme increased,16825014
1,5,22.0,Nausea,16825014
2,5,22.0,Cardiac arrest,16825014
0,1,22.0,Agranulocytosis,16825015
0,1,22.0,Leukopenia,16825016
1,1,22.0,Agranulocytosis,16825016
0,2,22.0,Leukopenia,16825017
0,1,22.1,Gastroenteritis viral,16825102
1,6,22.1,Disease progression,16825102
2,6,22.1,Product administered to patient of inappropriate age,16825102
3,6,22.1,Off label use,16825102
0,6,22.0,Thyroid disorder,16825126
1,3,22.0,Malignant neoplasm progression,16825126
2,6,22.0,Hyponatraemia,16825126
0,6,22.0,Metastases to retroperitoneum,16825154
1,6,22.0,Anaemia,16825154
2,6,22.0,Neutropenia,16825154
3,6,22.0,Metastases to lymph nodes,16825154
4,6,22.0,Metastases to lymph nodes,16825154
5,6,22.0,Metastases to central nervous system,16825154
6,6,22.0,Thrombocytopenia,16825154
7,6,22.0,Bone marrow failure,16825154
0,6,22.1,Osteonecrosis of jaw,16825174
0,5,22.0,Organ failure,16825260
1,5,22.0,Malignant neoplasm progression,16825260
0,2,22.0,Agranulocytosis,16825263
0,6,22.0,Pneumonitis,16825280
1,6,22.0,Off label use,16825280
0,6,22.1,Hepatic cirrhosis,16825335
1,6,22.1,Varices oesophageal,16825335
2,6,22.1,Metastases to peritoneum,16825335
3,6,22.1,Metastases to lymph nodes,16825335
0,1,22.0,Agranulocytosis,16825361
1,1,22.0,Leukopenia,16825361
0,1,22.0,Leukopenia,16825364
1,1,22.0,Agranulocytosis,16825364
0,2,22.0,Leukopenia,16825365
1,2,22.0,Agranulocytosis,16825365
0,1,22.0,Leukopenia,16825366
1,1,22.0,Agranulocytosis,16825366
0,1,22.0,Agranulocytosis,16825367
1,1,22.0,Leukopenia,16825367
0,6,22.0,Drug resistance,16825371
1,6,22.0,Disease progression,16825371
0,3,22.1,Onychoclasis,16825378
1,6,22.1,Gastritis,16825378
2,6,22.1,Bone marrow failure,16825378
3,3,22.1,White blood cell count decreased,16825378
4,6,22.1,Fatigue,16825378
5,3,22.1,Red blood cell count decreased,16825378
6,6,22.1,Alopecia,16825378
0,6,22.0,Tinnitus,16825394
1,6,22.0,Acne,16825394
2,1,22.0,Abdominal distension,16825394
3,1,22.0,Heart rate increased,16825394
4,6,22.0,Dyspepsia,16825394
5,6,22.0,Flatulence,16825394
6,6,22.0,Insomnia,16825394
7,3,22.0,Constipation,16825394
8,6,22.0,Nausea,16825394
0,1,22.0,Leukopenia,16825418
1,1,22.0,Agranulocytosis,16825418
0,6,22.1,Cholecystitis,16825433
0,6,22.0,Immune system disorder,16825442
0,6,22.0,Pneumonitis,16825473
0,1,22.1,Epilepsy,16825482
0,6,22.1,Hepatic lesion,16825483
1,2,22.1,Prostatic specific antigen increased,16825483
2,1,22.1,Anaemia,16825483
3,6,22.1,Dehydration,16825483
0,2,22.1,Hepatic cirrhosis,16825484
1,2,22.1,Platelet count decreased,16825484
0,1,22.0,Erosive duodenitis,16825485
1,1,22.0,Gastrooesophageal reflux disease,16825485
2,1,22.0,Gastritis,16825485
3,1,22.0,Diarrhoea,16825485
0,3,22.0,Tremor,16825486
1,3,22.0,Hypoaesthesia,16825486
2,3,22.0,Sleep disorder,16825486
3,3,22.0,Hiccups,16825486
0,1,22.0,Bone marrow failure,16825487
0,6,22.0,Pneumonitis,16825588
0,2,22.0,Hyperaesthesia,16825589
0,2,22.0,Thrombocytopenia,16825671
0,1,22.0,Hepatic function abnormal,16825688
0,2,22.0,Photosensitivity reaction,16825689
1,2,22.0,Lichenoid keratosis,16825689
0,6,22.0,Lichenoid keratosis,16825692
1,6,22.0,Photodermatosis,16825692
0,2,22.1,Platelet count decreased,16825695
0,6,22.0,Cardiac dysfunction,16825721
0,1,22.1,Enterocolitis,16825722
1,6,22.1,Hepatic function abnormal,16825722
2,1,22.1,Diarrhoea,16825722
3,6,22.1,Stomatitis,16825722
4,1,22.1,Febrile neutropenia,16825722
0,6,22.1,Metastases to bone,16825726
1,6,22.1,Pain,16825726
2,6,22.1,Malignant neoplasm progression,16825726
3,6,22.1,Bone marrow infiltration,16825726
4,6,22.1,Drug ineffective,16825726
0,6,22.0,Hepatitis,16825733
0,1,22.0,Infection,16825747
1,1,22.0,Pyrexia,16825747
0,6,22.0,Acute myeloid leukaemia,16825755
0,6,22.0,Weight increased,16825765
1,3,22.0,Metastases to lung,16825765
2,2,22.0,Dermatitis acneiform,16825765
0,3,22.0,Somnolence,16825787
1,3,22.0,Pyrexia,16825787
2,6,22.0,Fatigue,16825787
3,3,22.0,Influenza,16825787
4,3,22.0,Back pain,16825787
5,3,22.0,Dyspnoea,16825787
6,3,22.0,Pruritus generalised,16825787
7,3,22.0,Trichorrhexis,16825787
8,6,22.0,Off label use,16825787
9,3,22.0,Nausea,16825787
10,3,22.0,Bone pain,16825787
11,3,22.0,Urinary tract inflammation,16825787
12,3,22.0,Rash,16825787
0,6,22.1,Pleural effusion,16825919
1,6,22.1,Cerebral infarction,16825919
2,5,22.1,Interstitial lung disease,16825919
0,6,22.0,Injection site bruising,16825965
1,6,22.0,Injection site swelling,16825965
2,6,22.0,Injection site erythema,16825965
0,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16825984
1,6,22.0,Neuropathy peripheral,16825984
2,6,22.0,Thrombocytopenia,16825984
0,6,22.0,Therapy non-responder,16825985
0,6,22.0,Therapy non-responder,16825986
0,6,22.0,Therapy non-responder,16825987
0,6,22.0,Thrombocytopenia,16825988
1,6,22.0,Therapy partial responder,16825988
0,6,22.0,Therapy non-responder,16825991
0,6,22.0,Heparin-induced thrombocytopenia,16826002
0,6,22.0,Paraesthesia,16826083
1,6,22.0,Pain,16826083
2,6,22.0,Headache,16826083
3,6,22.0,Pruritus,16826083
4,6,22.0,Odynophagia,16826083
5,6,22.0,Restlessness,16826083
6,6,22.0,Ear pain,16826083
0,1,22.0,Neutropenia,16826101
1,1,22.0,Pyrexia,16826101
2,1,22.0,Haematuria,16826101
3,1,22.0,Thrombocytopenia,16826101
0,6,22.0,Epistaxis,16826109
1,6,22.0,Lung disorder,16826109
2,6,22.0,Immunodeficiency,16826109
3,6,22.0,Deafness,16826109
4,6,22.0,Asthenia,16826109
5,6,22.0,Ear haemorrhage,16826109
0,1,22.0,Acute kidney injury,16826114
1,1,22.0,Stomatitis,16826114
2,1,22.0,Pancytopenia,16826114
3,1,22.0,Dysphagia,16826114
4,1,22.0,General physical health deterioration,16826114
5,1,22.0,Hyperkalaemia,16826114
